share_log

Rocket Is a Late-stage Biotech Co Focused on Genetic Therapies for Rare Childhood Disorders >RCKT

Rocket Is a Late-stage Biotech Co Focused on Genetic Therapies for Rare Childhood Disorders >RCKT

Rocket是一家晚期生物技術公司,專注於罕見兒童疾病的基因療法>RCKT
道瓊斯 ·  2022/10/03 23:26

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論